ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2019, Vol. 28 ›› Issue (2): 151-155.DOI: 10.3969/j.issn.1006-298X.2019.02.012

• 论文 • 上一篇    下一篇

毛细血管渗漏综合征研究进展

  

  • 出版日期:2019-04-28 发布日期:2019-05-06

Progress of capillary leakage syndrome

  • Online:2019-04-28 Published:2019-05-06

摘要:

毛细血管渗漏综合征(CLS)是以体液和蛋白从血管渗漏到组织间隙为特征的临床综合征,可累及全身多个脏器,表现为全身进行性水肿、胸腔和腹腔积液、少尿、低血压、低氧血症和低白蛋白血症。CLS常引起急性肾损伤。液体治疗是治疗CLS的关键环节,人工胶体液可作为CLS渗漏期的复苏液体,恢复期应警惕非心源性肺水肿。糖皮质激素对多种疾病诱发的CLS有效。大剂量免疫球蛋白可能是治疗CLS的有效方法。

 

关键词: 毛细血管渗漏综合征, 毛细血管渗透性, 细胞因子, 急性肾损伤

Abstract:

Capillary leak syndrome(CLS)is a serious complication of systemic inflammatory response syndrome,because of the cell injury of capillary endothelial,increased vascular permeability with a large number of plasma proteins leaking into the tissues.The clinical manifestations of CLS include progressive systemic edema,chest and abdominal cavity effusion,oliguria,hypotension,hypoxemia,hypoproteinemia,and  multiple organ failure in serious condition.Acute kidney injury is commonly seen in CLS.Fluid management is a critical part of the treatment of CLSHigh molecular weight starches are theoretically attractive resuscitative fluids in those with capillary leak.Patients with CLS are at high risk of noncardiogenic pulmonary edema during fluid resuscitation.Steroids are effective in several causes of CLS.An effective abortive treatment in CLS appears to be highdose intravenous immunoglobulins.

Key words: capillary leak syndrome, capillary permeability, cytokines, acute kidney injury